Immunotherapy in renal cell carcinoma: latest evidence and clinical implications

Advances in understanding the mechanisms of tumour-induced immunosuppression have led to the development of immune-checkpoint inhibitors in cancer patients, including those with renal cell carcinoma (RCC). The optimal combination between immunotherapy and targeted agents (as well as the possible fav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Context
Main Authors: Santoni, Matteo, Massari, Francesco, Di Nunno, Vincenzo, Conti, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Montironi, Rodolfo, Cheng, Liang, Battelli, Nicola, Lopez-Beltran, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: BioExcel Publishing Ltd 2018
Assuntos:
Editorial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992965/
https://ncbi.nlm.nih.gov/pubmed/29899754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212528
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados